Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®

Jean Bousquet; Bernardo Sousa-Pinto; Josep M. Anto; Anna Bedbrook; Wienczyslawa Czarlewski; Ignacio J. Ansotegui; Karl C. Bergmann; Fulvio Braido; Luisa Brussino; Lorenzo Cecchi; Claudia Chaves Loureiro; Alvaro A. Cruz; Philippe Devillier; Alessandro Fiocchi; Bilun Gemicioglu; Tari Haahtela; Juan Carlos Ivancevich; Ludger Klimek; Marek Kulus; Piotr Kuna; Maciej Kupczyk; Violeta Kvedariene; Desiree E. Larenas-Linnemann; Gilles Louis; Renaud Louis; Michael Makris; Mario Morais-Almeida; Marek Niedoszytko; Ken Ohta; Markus Ollert; Nikolaos Papadopoulos; Vincenzo Patella; Benoit Pétré; Oliver Pfaar; Francesca Puggioni; Santiago Quirce; Frederico S. Regateiro; Nicolas Roche; Philip W. Rouadi; Boleslaw Samolinski; Joaquin Sastre; Florence Schleich; Nicola Scichilone; Luis Taborda-Barata; Sanna Toppila-Salmi; Arunas Valiulis; Ilgim Vardaloglu Koyuncu; Maria Teresa Ventura; Arzu Yorgancioglu; Joao A. Fonseca; Torsten Zuberbier

doi:10.1002/clt2.12390

Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air^®

Jean Bousquet^*, Bernardo Sousa-Pinto, Josep M. Anto, Anna Bedbrook, Wienczyslawa Czarlewski, Ignacio J. Ansotegui, Karl C. Bergmann, Fulvio Braido, Luisa Brussino, Lorenzo Cecchi, Claudia Chaves Loureiro, Alvaro A. Cruz, Philippe Devillier, Alessandro Fiocchi, Bilun Gemicioglu, Tari Haahtela, Juan Carlos Ivancevich, Ludger Klimek, Marek Kulus, Piotr KunaMaciej Kupczyk, Violeta Kvedariene, Desiree E. Larenas-Linnemann, Gilles Louis, Renaud Louis, Michael Makris, Mario Morais-Almeida, Marek Niedoszytko, Ken Ohta, Markus Ollert, Nikolaos Papadopoulos, Vincenzo Patella, Benoit Pétré, Oliver Pfaar, Francesca Puggioni, Santiago Quirce, Frederico S. Regateiro, Nicolas Roche, Philip W. Rouadi, Boleslaw Samolinski, Joaquin Sastre, Florence Schleich, Nicola Scichilone, Luis Taborda-Barata, Sanna Toppila-Salmi, Arunas Valiulis, Ilgim Vardaloglu Koyuncu, Maria Teresa Ventura, Arzu Yorgancioglu, Joao A. Fonseca, Torsten Zuberbier

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air^® (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air^® in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.

Original language	English
Article number	e12390
Journal	Clinical and Translational Allergy
Volume	14
Issue number	9
DOIs	https://doi.org/10.1002/clt2.12390
Publication status	Published - Sept 2024

Keywords

asthma
digital health
EQ-5D
rhinitis
visual analogue scale

Access to Document

10.1002/clt2.12390Licence: CC BY

Cite this

Bousquet, J., Sousa-Pinto, B., Anto, J. M., Bedbrook, A., Czarlewski, W., Ansotegui, I. J., Bergmann, K. C., Braido, F., Brussino, L., Cecchi, L., Loureiro, C. C., Cruz, A. A., Devillier, P., Fiocchi, A., Gemicioglu, B., Haahtela, T., Ivancevich, J. C., Klimek, L., Kulus, M., ... Zuberbier, T. (2024). Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air^®. Clinical and Translational Allergy, 14(9), Article e12390. https://doi.org/10.1002/clt2.12390

@article{d2cc8bcd1f4a415e9557adc99cfeda30,

title = "Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air{\textregistered}",

abstract = "Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air{\textregistered} (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air{\textregistered} in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.",

keywords = "asthma, digital health, EQ-5D, rhinitis, visual analogue scale",

author = "Jean Bousquet and Bernardo Sousa-Pinto and Anto, {Josep M.} and Anna Bedbrook and Wienczyslawa Czarlewski and Ansotegui, {Ignacio J.} and Bergmann, {Karl C.} and Fulvio Braido and Luisa Brussino and Lorenzo Cecchi and Loureiro, {Claudia Chaves} and Cruz, {Alvaro A.} and Philippe Devillier and Alessandro Fiocchi and Bilun Gemicioglu and Tari Haahtela and Ivancevich, {Juan Carlos} and Ludger Klimek and Marek Kulus and Piotr Kuna and Maciej Kupczyk and Violeta Kvedariene and Larenas-Linnemann, {Desiree E.} and Gilles Louis and Renaud Louis and Michael Makris and Mario Morais-Almeida and Marek Niedoszytko and Ken Ohta and Markus Ollert and Nikolaos Papadopoulos and Vincenzo Patella and Benoit P{\'e}tr{\'e} and Oliver Pfaar and Francesca Puggioni and Santiago Quirce and Regateiro, {Frederico S.} and Nicolas Roche and Rouadi, {Philip W.} and Boleslaw Samolinski and Joaquin Sastre and Florence Schleich and Nicola Scichilone and Luis Taborda-Barata and Sanna Toppila-Salmi and Arunas Valiulis and {Vardaloglu Koyuncu}, Ilgim and Ventura, {Maria Teresa} and Arzu Yorgancioglu and Fonseca, {Joao A.} and Torsten Zuberbier",

note = "Grants and funding ARIA Climate Action To Advance HeaLthY Societies in Europe (CATALYSE) 101057131/the European Union's Horizon Europe research and innovation programme Publisher Copyright: {\textcopyright} 2024 The Author(s). Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.",

year = "2024",

month = sep,

doi = "10.1002/clt2.12390",

language = "English",

volume = "14",

journal = "Clinical and Translational Allergy",

issn = "2045-7022",

publisher = "John Wiley & Sons Inc.",

number = "9",

}

Bousquet, J, Sousa-Pinto, B, Anto, JM, Bedbrook, A, Czarlewski, W, Ansotegui, IJ, Bergmann, KC, Braido, F, Brussino, L, Cecchi, L, Loureiro, CC, Cruz, AA, Devillier, P, Fiocchi, A, Gemicioglu, B, Haahtela, T, Ivancevich, JC, Klimek, L, Kulus, M, Kuna, P, Kupczyk, M, Kvedariene, V, Larenas-Linnemann, DE, Louis, G, Louis, R, Makris, M, Morais-Almeida, M, Niedoszytko, M, Ohta, K, Ollert, M, Papadopoulos, N, Patella, V, Pétré, B, Pfaar, O, Puggioni, F, Quirce, S, Regateiro, FS, Roche, N, Rouadi, PW, Samolinski, B, Sastre, J, Schleich, F, Scichilone, N, Taborda-Barata, L, Toppila-Salmi, S, Valiulis, A, Vardaloglu Koyuncu, I, Ventura, MT, Yorgancioglu, A, Fonseca, JA & Zuberbier, T 2024, 'Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air^®', Clinical and Translational Allergy, vol. 14, no. 9, e12390. https://doi.org/10.1002/clt2.12390

TY - JOUR

T1 - Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®

AU - Bousquet, Jean

AU - Sousa-Pinto, Bernardo

AU - Anto, Josep M.

AU - Bedbrook, Anna

AU - Czarlewski, Wienczyslawa

AU - Ansotegui, Ignacio J.

AU - Bergmann, Karl C.

AU - Braido, Fulvio

AU - Brussino, Luisa

AU - Cecchi, Lorenzo

AU - Loureiro, Claudia Chaves

AU - Cruz, Alvaro A.

AU - Devillier, Philippe

AU - Fiocchi, Alessandro

AU - Gemicioglu, Bilun

AU - Haahtela, Tari

AU - Ivancevich, Juan Carlos

AU - Klimek, Ludger

AU - Kulus, Marek

AU - Kuna, Piotr

AU - Kupczyk, Maciej

AU - Kvedariene, Violeta

AU - Larenas-Linnemann, Desiree E.

AU - Louis, Gilles

AU - Louis, Renaud

AU - Makris, Michael

AU - Morais-Almeida, Mario

AU - Niedoszytko, Marek

AU - Ohta, Ken

AU - Ollert, Markus

AU - Papadopoulos, Nikolaos

AU - Patella, Vincenzo

AU - Pétré, Benoit

AU - Pfaar, Oliver

AU - Puggioni, Francesca

AU - Quirce, Santiago

AU - Regateiro, Frederico S.

AU - Roche, Nicolas

AU - Rouadi, Philip W.

AU - Samolinski, Boleslaw

AU - Sastre, Joaquin

AU - Schleich, Florence

AU - Scichilone, Nicola

AU - Taborda-Barata, Luis

AU - Toppila-Salmi, Sanna

AU - Valiulis, Arunas

AU - Vardaloglu Koyuncu, Ilgim

AU - Ventura, Maria Teresa

AU - Yorgancioglu, Arzu

AU - Fonseca, Joao A.

AU - Zuberbier, Torsten

N1 - Grants and funding ARIA Climate Action To Advance HeaLthY Societies in Europe (CATALYSE) 101057131/the European Union's Horizon Europe research and innovation programme Publisher Copyright: © 2024 The Author(s). Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.

PY - 2024/9

Y1 - 2024/9

N2 - Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air® (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air® in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.

AB - Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air® (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air® in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.

KW - asthma

KW - digital health

KW - EQ-5D

KW - rhinitis

KW - visual analogue scale

UR - http://www.scopus.com/inward/record.url?scp=85204804568&partnerID=8YFLogxK

UR - https://pubmed.ncbi.nlm.nih.gov/39313483/

U2 - 10.1002/clt2.12390

DO - 10.1002/clt2.12390

M3 - Article

C2 - 39313483

AN - SCOPUS:85204804568

SN - 2045-7022

VL - 14

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

IS - 9

M1 - e12390

ER -

Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air^®

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this